Business StandardCenter·
Industry seeks one-time price hike as cancer drug shortage worsens
Pharmaceutical companies have urged the government to revise prices of cisplatin and carboplatin as soaring platinum costs and raw material constraints disrupt supplies
Read at Business Standard →

